NextSource Materials Inc. (TSX:NEXT, OTCQB:NSRCF) president and CEO Hanré Rossouw talked with Proactive about the company’s definitive feasibility study for its active anode material project in Abu Dhabi.
Rossouw said the development marks a “pivotal moment” for NextSource as it positions itself as one of the largest non-Chinese producers of battery anode material for electric vehicles and grid-scale storage.
Pantheon Resources PLC (AIM:PANR, OTCQX:PTHRF) chief executive Max Easley and Chief Development Officer Erich Krumanocker spoke with Proactive about the company’s transition from development to production at the Dubhe-1 well in Alaska.
They discussed recent operational milestones, including a large-scale well completion, and outlined next steps as Pantheon targets first production.
TNR Gold Corp (TSX-V:TNR, OTC:TRRXF) announced that McEwen Inc has released a positive Feasibility Study for the Los Azules copper, gold, and silver project in San Juan, Argentina.
TNR holds a 0.4% net smelter returns royalty (NSR royalty) on the project, including 0.04% on behalf of a shareholder.
Happy Creek Minerals Ltd. (TSX-V:HPY, OTC:HPYCF) has announced several corporate developments, including a change in chief financial officer, amended terms to the sale of its Highland Valley Project, updates related to royalties on its Cariboo properties, and the issuance of stock options.
The company said on Friday that Richard Lee, CPA, CMA, has retired and stepped down as chief financial officer and corporate secretary, effective immediately.
Gunnison Copper Corp (TSX:GCU, OTCQB:GCUMF) announced that it intends to raise gross proceeds of up to C$15 million in a non-brokered, private placement financing by selling up to about 33.33 million company units at a price of C$0.45 per unit.
The multi-asset, pure-play copper developer and producer said it intends to use the net proceeds from the offering for drilling, metallurgical testing and permitting activities that will be incorporated in a pre-feasibility study for the Gunnison Copper Project, funding US head office general and administrative expenses, partial repayment of outstanding debt due to Nebari, and for general working capital purposes.
GenIP Plc (LSE:GNIP) has announced the launch of Invention Validator, a new product designed to assess user adoption readiness for emerging technologies.
A pilot project is underway with a South African research university evaluating an agricultural biotech innovation.
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF), the London-listed longevity company, has reached a key milestone in its effort to see whether a human gene linked to long life can slow ageing in dogs.
The company said its experimental SIRT6 gene therapy, based on a version found in people who live beyond 100, had been safely given for the second time to a group of elderly beagles with no signs of side effects.
Prescient Therapeutics Ltd (ASX:PTX, OTC:PSTTF) reported a cash balance of A$12.32 million at September 30, following a Share Purchase Plan and placement that together raised A$9.8 million before costs at A$0.04 per share, supporting the phase 2 programme for first-in-class cancer therapy PTX-100.
Net operating cash outflow was A$4.1 million for the quarter, including A$2.8 million on research and development and clinical activities. The company noted timing effects, with A$2.7 million of June 30 payables settled in the period, skewing the reported 3.1-quarter runway; operating expenditure incurred and settled in the quarter was A$1.4 million. Payments to related parties were A$85,000 for non-executive director fees.
Kairos Minerals Ltd (ASX:KAI, OTCQB:KAIFF) has signed a Mineral Rights Agreement (MRA) with PLS, securing all mineral rights other than lithium and tantalum across three PLS exploration licences and one application totalling 367 square kilometres, and clearing early access to a ‘Priority Area’ to start drilling.
The MRA follows Kairos’ August 2024 sale of non-core assets to PLS and reflects non-binding key terms agreed under the Tenement Sale Agreement (TSA) signed on July 30, 2024. Under the MRA, Kairos will pay a 2% gross-revenue royalty on any minerals recovered and sold from the relevant licences.